Camrelizumab(SHR-1210) Combined With Apatinib in the Treatment of Advanced Metastatic Colorectal Cancer
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The incidence and mortality of colorectal cancer in China's cancer disease spectrum is on the
rise, and it is a common malignant tumor that harms the health of Chinese residents.This
study was a one-arm, single-center, open clinical study. A total of 50 patients were enrolled
in the study.